REVIEW JNJ-38158471 is a well tolerated, orally available, highly selective VEGFR-2 inhibitor with an IC50 of 40 nM. It also inhibits closely related tyrosine kinases such as Ret (IC50 of 180 nM) and Kit (C50 of 500 nM). It has no significant activity (>1 uM) against VEGFR-1 and VEGFR-3.
All products are stocked and shipped from San Francisco Bay Area, California, USA.
⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.